Cargando…
Immunology of COVID‐19 and disease‐modifying therapies: The good, the bad and the unknown
OBJECTIVE: The outbreak of the SARS‐CoV‐2 pandemic, caused by a previously unknown infectious agent, posed unprecedented challenges to healthcare systems and unmasked their vulnerability and limitations worldwide. Patients with long‐term immunomodulatory/suppressive therapies, as well as their physi...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2020
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7675490/ https://www.ncbi.nlm.nih.gov/pubmed/33090599 http://dx.doi.org/10.1111/ene.14578 |